Hepatitis B surface antigen reduction as a result of switching from long‐term entecavir administration to tenofovir
Author:
Affiliation:
1. Department of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan
2. First Department of Internal Medicine, Faculty of Medicine University of Yamanashi Kofu Japan
Funder
Japan Agency for Medical Research and Development
Publisher
Wiley
Subject
Gastroenterology,Hepatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgh3.12273
Reference27 articles.
1. Hepatitis B Virus Infection
2. Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection
3. JSH Guidelines for the Management of Hepatitis B Virus Infection
4. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
5. Three Years of Continuous Entecavir Therapy in Treatment-Naïve Chronic Hepatitis B Patients: VIRAL Suppression, Viral Resistance, and Clinical Safety
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-Term Outcomes after Switching to Tenofovir Alafenamide in Patients with Chronic Hepatitis B;International Journal of Molecular Sciences;2024-02-13
2. Dynamic evaluation of liver fibrosis to assess hepatocellular carcinoma risk in patients with chronic hepatitis B receiving nucleoside analogs treatment;Revista do Instituto de Medicina Tropical de São Paulo;2024
3. Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B;JGH Open;2023-07-21
4. Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study;Canadian Journal of Gastroenterology and Hepatology;2022-12-07
5. Superiority of tenofovir alafenamide fumarate over entecavir for serum HBsAg level reduction in patients with chronic HBV infection: A 144-week outcome study after switching of the nucleos(t)ide analog;PLOS ONE;2022-02-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3